Abstract: In order to solve the problem that the existing manganese-based positive electrode material battery has insufficient high-temperature cycle and high-temperature storage performances due to the dissolution of manganese ions, the present application provides a secondary battery, comprising a positive electrode, a negative electrode and a non-aqueous electrolyte, the positive electrode comprises a positive electrode material layer containing a positive electrode active material, the positive electrode active material comprises a manganese-based material, and the non-aqueous electrolyte comprises a solvent, an electrolyte salt and an additive, and the additive comprises a compound represented by structural formula 1: the secondary battery meets the following requirements: 0.05?100×W×u/(q×s)?5; and 2.0 g/Ah?W?4.5 g/Ah, 0.05%?u?3.5%, 5%?q?65%, 10 mg/cm2?s?30 mg/cm2.

Abstract: A semiconductor device includes a semiconductor substrate, an epitaxial layer disposed on the semiconductor substrate, a cell zone including multiple unit cells disposed in the epitaxial layer opposite to the semiconductor substrate, a transition zone having a doped region and surrounding the cell zone, a source electrode unit disposed on the epitaxial layer opposite to the semiconductor substrate, and multiple gate electrode units. Each unit cell includes a well region, a source region disposed in the well region, and a well contact region extending through the source region to contact the well region. A method for manufacturing the semiconductor device is also disclosed.

Abstract: Electrical equipment is provided. The electrical equipment includes a box body, a device, and a sealing member having both an electromagnetic shielding function and a sealing function. The device is detachably fixed on the box body, the sealing member is disposed between the box body and the device, and the base surface of the device can be attached to the installation surface of the box body, such that the sealing member can ensure the sealing installation of the box body and the device, and can also enable the base surface of the device to be closely attached to the installation surface of the box body to ensure the electromagnetic shielding function of conductive contact between the box body and the device.

Abstract: The present disclosure relates to a method and system for evaluating the macro resilience of offshore oil well control equipment. The method for evaluating the macro resilience of offshore oil well control equipment comprises six steps: determining the type and strength of external disaster; calculating the failure rate of components; calculating the recovery rate of the components; modeling the BN for a degradation process; modeling the BN for a maintenance process; and calculating the resilience of the offshore oil well control equipment. A system for evaluating the macro resilience of offshore oil well control equipment comprises an external disaster evaluation module, a component failure rate calculation subsystem, a reliability degradation process simulation module, a fault identification module, a component recovery rate calculation module, a reliability recovery process simulation module, a reliability change curve derivation unit and an resilience calculation unit.

Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.

Abstract: Disclosed are a nitrogen-containing heterocyclic compound as shown in formula (I), or a stereoisomer, a solvate, a deuterated form, a pharmaceutically acceptable salt, or a cocrystal thereof or a pharmaceutical composition containing same, and the use thereof in the preparation of a drug for treating/preventing diseases mediated by autotaxin. Each group in formula (I) is as defined in the description.

Abstract: A wavelength selective switch includes an optical fiber array, a multiplexing/demultiplexing component, and a transmission direction adjustment component. The optical fiber array includes a first optical fiber and at least one second optical fiber. The first offset is used to compensate for a second offset of a diffraction spectrum generated when a plurality of single-wavelength optical signals obtained after an optical input signal is processed by the multiplexing/demultiplexing component arrive at the transmission direction adjustment component, so that the second offset of the diffraction spectrum of the plurality of single-wavelength optical signals arriving at the transmission direction adjustment component is 0 or may be ignored. An optical system has a simple structure, and no optical element needs to be added. This increases optical design freedom, facilitates optical path system commissioning, and reduces reliability risks and costs of subsequent products.

Abstract: A wiring device of photovoltaic power generation equipment includes an aluminum wire and a copper-aluminum transition element. One end of the aluminum end is connected with the aluminum end of the copper-aluminum transition piece, and the other end of the aluminum end is configured to connect with an external connecting component. The copper end is configured to connect with photovoltaic power generation equipment. In the wiring device of the photovoltaic power generation equipment provided in the present application, the copper-aluminum transition piece is arranged at the position of the photovoltaic power generation equipment, and the aluminum end of the copper-aluminum transition piece is connected to the external connecting component by the aluminum wire, avoiding using copper wire for long-distance conduction. The cost of the aluminum wire is much lower than that of the copper wire. Therefore, the cost of the wiring device provided by the application is reduced.

Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.

Abstract: A wiring device of photovoltaic power generation equipment includes an aluminum wire and a copper-aluminum transition element. One end of the aluminum end is connected with the aluminum end of the copper-aluminum transition piece, and the other end of the aluminum end is configured to connect with an external connecting component. The copper end is configured to connect with photovoltaic power generation equipment. In the wiring device of the photovoltaic power generation equipment provided in the present application, the copper-aluminum transition piece is arranged at the position of the photovoltaic power generation equipment, and the aluminum end of the copper-aluminum transition piece is connected to the external connecting component by the aluminum wire, avoiding using copper wire for long-distance conduction. The cost of the aluminum wire is much lower than that of the copper wire. Therefore, the cost of the wiring device provided by the application is reduced.

Abstract: The present invention provides compositions and methods based on genetic polymorphisms that are associated with autoinflammatory diseases such as psoriasis. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.

Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.

Abstract: Disclosed is a method for prophylaxis or treatment of infection of a virus, or for modulating innate immunity, in a subject comprising administering to the subject a therapeutically effective amount of a PUM1 inhibitor. A pharmaceutical composition comprising the PUM1 inhibitor is also disclosed.

Abstract: A case and an electronic device having the case are provided according to the present application. A fan is arranged on a case wall of the case, an air inlet and an air outlet in communication with the air inlet are arranged in the case wall. The fan is arranged inside the case and is located between the air inlet and the air outlet. Each of the fan is mounted in a bottom-to-top manner with its air inlet facing downwards and its air outlet facing upwards. The air inlet is located at a lower end of the case, the air outlet is located at an upper end of the case, and an air duct from bottom to top is formed by the air inlet, the fan and the air outlet.

Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.

Abstract: The invention relates to a process cartridge, which comprises a process cartridge housing, a photosensitive member, a driving force receiving opening, a retractable mechanism and a control mechanism, wherein the photosensitive member is arranged inside the process cartridge housing; the driving force receiving opening is connected with the photosensitive member and provides a driving force for the photosensitive member; the retractable mechanism allows the driving force receiving opening to extend or retract in the axial direction of the photosensitive member; and the control mechanism controls the extension and retraction of the retractable mechanism.

Abstract: The present invention is based on the discovery of genetic polymorphisms that are associated with psoriasis and related pathologies. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, including groups of nucleic acid molecules that may be used as a signature marker set, such as a haplotype, a diplotype, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.

Abstract: A combined inverter is arranged, which includes at least two separate box bodies connected detachably, all components of the combined inverter are placed into the box bodies separately, and at least one electrical connection terminal is arranged outside each of the box bodies, and the electrical connection terminal of one of the box bodies is capable of being connected to the electrical connection terminal of another of the box bodies. Therefore, a structure connection and an electrical connection of the combined inverter is achieved, weight of the whole combined inverter is dismantled effectively on the premise of ensuring normal operation of the combined inverter, construction difficult of installation and transportation is reduced, and the combined inverter has high applicability even when having high power.